Eping, Adzmar .

HRN: 26-35-48  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/09/2024
METRONIDAZOLE 125MG/5ML, 60ML (BOT)
12/09/2024
12/15/2024
PO
3.5ml
TID
Amoebiasis
Waiting Final Action 
12/09/2024
CEFTRIAXONE 1G (VIAL)
12/09/2024
12/15/2024
IVTT
870mg
OD
PCAP C
Waiting Final Action 
12/12/2024
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/12/2024
12/19/2024
IV
700mg
Q6hours
PCAP-C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: